The 20 Best Acute Lymphoblastic Leukemia (ALL) Doctors in New Jersey, US

Peter Cole is a Hematologist and an Oncologist in New Brunswick, New Jersey. Dr. Cole is rated as an Elite provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Classical Hodgkin Lymphoma. Dr. Cole is currently accepting new patients.

Christina Cho is a Hematologist in Hackensack, New Jersey. Dr. Cho is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Colonoscopy.

Jamie Koprivnikar is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Koprivnikar is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Endoscopy.

James Mccloskey is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Mccloskey is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Colonoscopy.

Michele Donato is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Donato is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy.

Teena Bhatla is a Hematologist and an Oncologist in Newark, New Jersey. Dr. Bhatla is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Sickle Cell Disease, and Adult Soft Tissue Sarcoma. Dr. Bhatla is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Stefan Faderl is an Oncologist in Hackensack, New Jersey. Dr. Faderl is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dale Schaar is a Hematologist and an Oncologist in New Brunswick, New Jersey. Dr. Schaar is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Aspiration. Dr. Schaar is currently accepting new patients.

Stuart Goldberg is a Hematologist in Hackensack, New Jersey. Dr. Goldberg is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Tissue Biopsy.

Burton Appel is a Pediatric Hematologist Oncology provider in Hackensack, New Jersey. Dr. Appel is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Bone Marrow Aspiration.

Katherine Linder is a Hematologist and an Oncologist in Hackensack, New Jersey. Dr. Linder is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Hyung Suh is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Suh is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Jing Chen is a Pediatric Hematologist Oncology provider in Hackensack, New Jersey. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Megakaryoblastic Leukemia, Sickle Cell Disease, Hemoglobin SC Disease, and Bone Marrow Aspiration.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Aziz Nazha is a Hematologist and a Hematologist Oncology provider in Cherry Hill, New Jersey. Dr. Nazha is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Nazha is currently accepting new patients.

Joanne Filicko is an Oncologist and a Transplant Surgeon in Cherry Hill, New Jersey. Dr. Filicko is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Multiple Myeloma, and Bone Marrow Transplant. Dr. Filicko is currently accepting new patients.

Christopher Lawlor, MD, is an Atlantic Medical Group physician and the Division Chief of Pediatric Hematology and Oncology for the Valerie Fund Children’s Center. Board-certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics, and fellowship-trained in pediatric hematology and oncology, he specializes in blood disorders and cancers in children, adolescents, and young adults, treating children of all ages with benign and malignant disease.Dr. Lawlor has spent over 25 years dedicated to children and helping them overcome serious illness so that they can grow into healthy adults. Prior to coming to Atlantic Medical Group, he served as the medical director for Pediatric Specialists of Virginia Center for Cancer and Blood Disorders and was affiliated with prestigious Children’s National Hospital in the Washington, DC, area. In his accomplished career he has managed the unique needs of infants, children, adolescents, and young adults while employing the latest innovations and breakthroughs to help children with cancer and blood disorders. From diagnosis through recovery, Dr. Lawlor provides family- and child-centered care, ensuring that patients and families receive the supportive services necessary to help them through a critical illness. In addition, he is committed to long-term follow-up care, promoting ongoing health and wellness for pediatric cancer survivors. Dr. Lawlor has collaborated on research in pediatric cancer treatment, authored book chapters, and presented nationally and internationally on many aspects of pediatric hematology and oncology. He is a member of the Children’s Oncology Group and the Histiocyte Society.After earning his medical degree from New York Medical College, Dr. Lawlor completed both his residency and a fellowship in pediatric hematology and oncology at Children’s National Medical Center, Washington, DC, one of the top five children’s hospitals in the nation. He has been listed as a top doctor by the Washingtonian and Northern Virginia Magazine. Dr. Lawlor is a participating provider of the Atlantic Accountable Care Organization. Dr. Lawlor is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Osteosarcoma, Ewing Sarcoma, and Immune Thrombocytopenic Purpura (ITP).

Jeffrey Silberberg is a Hematologist and an Oncologist in Freehold Township, New Jersey. Dr. Silberberg is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Silberberg is currently accepting new patients.